No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examination centers. By the close of 2021, specifically December 31st, the company's network included 68 medical examination centers. Beyond these core activities, Rici Healthcare also offers health advisory services, nursing care, diagnostic testing, and leasing arrangements. The firm was established in 2000 and has its principal corporate office located in Shanghai, China.
www.rich-healthcare.comNo one on the platform currently holds 1526.HK.
No tracked institution reports a position in 1526.HK as of their last filing.
No one on the platform has traded 1526.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 16.6% | 15.5% | — | — | — | |
| Rev. Growth % | -4.4% | 7.7% | ||||
| Profit Margin % | 11.0% | 10.6% | 4.5% | |||
| Free Cash Flow Margin % | 20.1% | 17.6% | 3.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.7B | +25.3% | $-0.04 | $-0.04–$-0.04 | — | 1 |
| 2027 | $2.5B | +42.4% | $0.05 | $0.05–$0.05 | — | 1 |
| 2028 | $3.7B | +50.4% | $0.17 | $0.17–$0.17 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $4.65 |
| +0.00% |
| $688M |
| — |
| 2453.HKConcord Healthcare Grp Co Ltd | $0.74 | +4.23% | $580M | — |
| 3839.HKCPBIO Holding Company Limited | $8.42 | -1.29% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry